Larisa Rudenko
Direktor/Vorstandsmitglied bei BioDiem Ltd.
Profil
Larisa G.
Rudenko currently works at BioDiem Ltd., as Non-Independent Non-Executive Director from 2011 and Institute of Experimental Medicine, as Head-Virology Department.
Aktive Positionen von Larisa Rudenko
| Unternehmen | Position | Beginn |
|---|---|---|
BioDiem Ltd.
 BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | Direktor/Vorstandsmitglied | 22.10.2009 |
Institute of Experimental Medicine
 Institute of Experimental Medicine Miscellaneous Commercial ServicesCommercial Services The Institute of Experimental Medicine operates as a scientific research laboratory. | Corporate Officer/Principal | 28.02.2011 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
BioDiem Ltd.
BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | Health Technology |
Institute of Experimental Medicine
Institute of Experimental Medicine Miscellaneous Commercial ServicesCommercial Services The Institute of Experimental Medicine operates as a scientific research laboratory. | Commercial Services |